Delivery Order SPE2DB24D2205-SPE2DB25FEGFD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,265.19 to AmerisourceBergen Drug Corp for Fexofenadine HCL 180 mg tablets (500 count) with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The delivery location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,760.02 firm fixed price contract provides 4,562,878,752 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,533 units of Fexofenadine HCL 180 mg tablets. The $1,340.43 ceiling value contract has a completion date of September 21, 2022. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov) until June 2025, has an extensive history of providing pharmaceutical and medical products...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,352 units of Fexofenadine HCl 180 mg tablets. The firm-fixed-price contract has a ceiling value of $1,093.98 and will run through August 6, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,337.28, is for the delivery of 4,567,094,436 units of the drug Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation or subcontractors....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fexofenadine HCL 180 mg tablets. The order has a potential value of $1,536.75 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. Amerisourcebergen Drug Corp also holds an indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,249.54 firm-fixed-price delivery order is for the supply of 4,562,548,789 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of October 23, 2023 and is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fexofenadine HCl 180 mg tablets. The contract has a firm fixed price of $3,310.56 and an ultimate completion date of April 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,862,411 units of Fexofenadine HCL 180 mg tablets. The order has a firm fixed price of $2,630.27 and a completion date of September 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen has been awarded numerous other federal contracts by the DLA and other agencies, including a $7,570,000...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $1,640.52 firm fixed price contract is for the delivery of 4,558,478,347 units of Fexofenadine HCL 180 mg tablets. This order is made under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and will...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGFDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Fexofenadine HCl 180 mg tablets (500 count) with a ceiling value of $1,288.32. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support globally for military healthcare programs, enabling the company to deliver a broad range of medications, vaccines, and medical devices to support Department of Defense medical requirements. The delivery order demonstrates AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/13/25 |